Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...